Skip to evidence report

GRNLSA.p53_damage: Studies — page 4

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 3,001–4,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
3001EBAG9/TGFB1 ratioGCST903145704.11
3002Haemorrhoids | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedUKBB000002944.11
3003PI3 levelsGCST904702304.10
3004Total Alkenylphosphatidylcholine levelsGCST900258354.10
3005Disorders of plasma protein metabolism (PheCode 270.3)GCST904757094.10
3006SCARA5/SCARF2 ratioGCST903158084.10
3007Coronary atherosclerosisFING000003594.10
3008Sexual abuseGCST905518374.10
3009MTIF3 levelsGCST904699574.10
3010Metabolonic lactone sulfate levelsGCST902002574.10
3011Angina pectorisGCST900185734.10
3012CRADD/MAP4K5 ratioGCST903142404.10
3013SPP1 levelsGCST904707334.09
3014IDP dMRI TBSS MD Posterior thalamic radiation RGCST900040554.09
3015aparc-DKTatlas rh volume parahippocampalGCST900029074.09
3016NFX1 levelsGCST904700414.09
3017IDP dMRI TBSS MO Superior corona radiata LGCST900039774.09
3018Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T91ECGU0000914.08
3019Free cholesterol in LDL (UKB data field 23421)GCST902695184.08
3020Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T249ECGU0002494.08
3021C21orf58 levelsGCST906183804.08
3022Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335ECGU0003354.07
3023Phospholipids to Total Lipids in Small HDL percentageGCST904995054.07
3024Disorders of iris and ciliary body (PheCode 379.5)GCST904758994.07
3025Cholesterol to Total Lipids in Small VLDL percentageGCST904997644.07
3026Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T19ECGA0000194.07
3027Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T111ECGA0001114.07
3028PEBP1 levelsGCST904702054.07
30291-arachidonoylglycerophosphoinositol levelsGCST902437544.07
3030PTPRF/PTPRS ratioGCST903157514.07
3031ATF6 levelsGCST902408164.07
3032Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T164ECGA0001644.07
3033CSF1/IL10RB ratioGCST903142844.06
3034Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levelsGCST900602954.06
3035PTPN6 levelsGCST904703774.06
3036Phenylalanine levelsGCST902434074.06
3037ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cystGCST904542154.05
3038Drive faster than motorway speed limit | Physical activityUKBB000001944.05
3039Sphinganine-1-phosphate levelsGCST901998454.05
3040T1 FreeSurfer DKT rh insula areaGCST903843174.05
3041HippSubfield lh volume subiculum-headGCST900026714.05
3042Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024154.05
3043SUMF2 levelsGCST904707844.04
3044Age started wearing glasses (UKB data field 2217)GCST904681564.03
3045Low hand grip strength (60 years and older) (FNIH)GCST900075294.03
3046DTI TBSS L3 Cingulum hippocampus LGCST903845614.02
3047rfMRI amplitudes (ICA100 node 15)GCST900046034.02
3048GADD45GIP1 levelsGCST904692934.02
3049ERBB3/IL1R2 ratioGCST903146894.02
3050Telomere length (principal component 2)GCST904351454.01
3051GAL levelsGCST904693004.01
3052F11 levelsGCST904691654.01
3053Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T396ECGU0003964.01
3054Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T408ECGU0004084.01
3055X-12844 levelsGCST902005234.01
3056Peripheral artery diseaseGCST900186704.01
3057Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283ECGA0002834.00
3058HMBS/PKLR ratioGCST903150634.00
3059IGFBP3 levelsGCST904695294.00
3060CD83/LAMP3 ratioGCST903139064.00
3061Lymphoid neoplasms (P-cell phenocluster)GCST906247374.00
3062IDP dMRI ProbtrackX L3 ar lGCST900043004.00
3063ACYP1 levelsGCST904682143.99
3064FLT3 levelsGCST904692513.99
3065Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB000004293.99
3066SCG3 levelsGCST904705393.98
3067aseg global volume BrainSegNotVentGCST900025913.98
3068CD83 levelsGCST904686523.98
3069MNDA levelsGCST904699273.98
3070SERPINB1/SERPINB9 ratioGCST903158273.98
3071BA-exvivo rh volume BA1GCST900028493.98
3072FGFBP1 levelsGCST904692303.98
3073QDPR levelsGCST904704003.97
3074Linoleic acid levelsGCST905022943.97
3075CPM levelsGCST904688433.97
3076VWF levelsGCST904710653.96
3077Disorders of iron metabolism (PheCode 275.1)GCST904757433.96
3078SMPD1 levelsGCST904706843.96
3079FKBPL levelsGCST904692463.95
3080Phosphatidylcholine-O_33:3_[M+H]1+/Phosphatidylcholine-P_33:2_[M+H]1+/Phosphatidylethanolamine-O_36:3_[M+H]1+ levelsGCST900602613.95
3081PARP1 levelsGCST904701603.95
3082Triacylglycerol_53:3_[M+NH4]1+ levelsGCST900605283.94
3083Concentration of small LDL particlesGCST904996603.94
3084Phospholipid levels in VLDLGCST900930013.94
3085LDL cholesterol levelsGCST904983533.94
3086Cholesteryl ester levels in large VLDLGCST900928703.93
3087Alpha-hydroxyisovalerate levelsGCST901997363.93
3088PDGFRA levelsGCST904210933.93
3089C1R levelsGCST904684933.93
3090Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T185ECGU0001853.92
3091Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391ECGU0003913.92
3092N-acetyl-1-methylhistidine levelsGCST902006903.92
3093aparc-Desikan rh thickness transversetemporalGCST900035113.92
3094CD69/F2R ratioGCST903138773.91
3095RPE levelsGCST904704953.91
3096Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165ECGA0001653.91
3097Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409ECGU0004093.91
3098EPHB6/TNFRSF9 ratioGCST903146823.90
3099Total fatty acid levelsGCST905027103.90
3100CD69/CHMP1A ratioGCST903138683.89
3101Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB000005573.89
3102Spread type: Butter vs never use spread (UKB data field 1428)GCST901329523.89
3103ESAM/LAMA4 ratioGCST903147133.89
3104aseg global volume CC-AnteriorGCST900026113.89
3105BA-exvivo lh volume BA1GCST900028353.89
3106PTH levelsGCST904703723.89
3107aseg lh number HolesBeforeFixingGCST900026303.88
3108Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T88ECGU0000883.88
3109total cholesterol (mean, inv-norm transformed)GCST904764243.88
3110HSPB1 levelsGCST904694893.88
3111NFASC levelsGCST904700313.88
3112Cholesterol to Total Lipids in Medium VLDL percentageGCST904989193.87
3113AmbidextrousnessGCST900134203.87
3114SDK2 levelsGCST904705623.87
3115SDC4/SMAD1 ratioGCST903158203.87
3116HydroceleFING000006273.86
3117Takes medication for blood clot/ pulmonary embolism/ deep vein thrombosis (DVT)?GCST904752103.86
3118GRAP2/TYMP ratioGCST903149903.85
3119Descending aorta diameterGCST902673913.85
3120DTI autoptx L2 ptr l tractGCST903851853.85
3121End stage renal disease (PheCode 585.32)GCST904761263.85
3122aparc-pial rh area TotalSurfaceGCST900031743.85
3123TNFSF10 levelsGCST900120113.85
3124CCBL2 levelsGCST902417223.85
3125Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172ECGA0001723.84
3126SMAD2 levelsGCST904706763.84
3127CST1 levelsGCST904688933.84
3128Urine X-24798 levels in chronic kidney diseaseGCST902668023.83
3129Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139ECGA0001393.83
3130VPS53 levelsGCST904710483.83
3131MGLL/PTPN6 ratioGCST903154403.82
3132Chronic rhinitis, nasopharyngitis and pharyngitisFING000002973.82
3133Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T184ECGU0001843.82
3134BACH1/HEXIM1 ratioGCST903134403.82
3135INSR levelsGCST904696233.82
3136IDP dMRI TBSS ICVF Posterior limb of internal capsule RGCST900043453.81
3137Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T183ECGU0001833.81
3138PTRHD1 levelsGCST904703893.81
3139Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338ECGU0003383.81
3140PTPRS levelsGCST904703873.81
3141CX3CL1 levelsGCST900120743.80
3142Milk type used: Soy milk vs never have milk (UKB data field 1418)GCST901329433.80
3143Free Cholesterol to Total Lipids in Small VLDL percentageGCST904998323.80
3144C2/SSC5D ratioGCST903135553.80
3145APOD levelsGCST904683373.80
3146IDP dMRI ProbtrackX ICVF fmaGCST900043853.80
3147PDGFA/VEGFC ratioGCST903156223.80
3148Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T78ECGA0000783.80
3149T1 FreeSurfer BA rh BA3b exvivo areaGCST903855503.80
3150ULBP2 levelsGCST904710083.80
3151Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390ECGA0003903.80
3152aparc-a2009s rh area G-precentralGCST900033993.79
3153CPXM1/DKK1 ratioGCST903142183.79
3154PPCDC levelsGCST904702903.79
3155DPP4 levelsGCST904690333.79
3156Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T163ECGA0001633.78
3157PAK4 levelsGCST904701503.78
3158Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026693.78
3159PLIN3/VSIR ratioGCST903156793.78
3160Reticulocyte countGCST0046223.78
3161Gout (PheCode 274.1)GCST900436623.78
3162CD99/CD99L2 ratioGCST903139233.77
3163DTI autoptx FA atr r tractGCST903851153.77
3164aparc-a2009s lh volume G-front-inf-OpercularGCST900029363.77
3165DHEAS levelsGCST901996733.77
3166Hearing (confirmatory factor analysis Factor 32)GCST903093663.76
3167IDP dMRI ProbtrackX FA atr lGCST900039273.75
3168Phenylacetylglutamate levelsGCST902000693.75
3169GBP4 levelsGCST904693133.75
3170Triacylglycerol_45:4_[M+NH4]1+ levelsGCST900603333.75
3171Total Sphingomyelin levelsGCST900258423.75
3172MITD1/WWP2 ratioGCST903154583.75
3173Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T341ECGA0003413.75
3174QSOX1 levelsGCST904704023.75
3175aparc-a2009s lh area S-calcarineGCST900033403.74
3176IDP dMRI TBSS OD Superior corona radiata RGCST900044263.74
3177Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T337ECGU0003373.74
3178PKD1 levelsGCST904702403.74
3179Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T284ECGA0002843.74
3180CSNK2A1 levelsGCST904688893.74
3181IDP dMRI TBSS L1 FornixGCST900040803.74
3182SRC levelsGCST904707413.74
3183Left-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903026823.74
3184IDP T1 FAST ROIs R mid front gyrusGCST900024583.74
3185aparc-DKTatlas lh area lateraloccipitalGCST900032433.74
3186TNN levelsGCST904709273.73
3187APOB levelsUKBB000000413.73
3188Cholesteryl Esters to Total Lipids in Medium VLDL percentageGCST904989563.73
3189Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T178ECGU0001783.73
3190Triacylglycerol_54:5_[M+NH4]1+ levelsGCST900605393.73
3191Principal component-derived dietary pattern 40GCST901330453.72
3192QC SWI-to-T1 linear alignment discrepancyGCST900063523.72
3193SERPINA12 levelsGCST904705813.72
3194MSRA levelsGCST904699513.72
3195Phospholipids to Total Lipids in Small LDL percentageGCST904997003.72
3196EPCAM levelsGCST904691263.71
3197Concentration of IDL particles (UKB data field 23523)GCST902696203.71
3198Triglycerides to Total Lipids in Medium VLDL percentageGCST904990693.71
3199C-reactive protein levels (CRP.4337.49.2)GCST902405033.70
3200Left ventricular end systole anterolateral wall thicknessGCST902785113.69
3201AIFM1/SIRT2 ratioGCST903132213.69
3202Vanillactate levelsGCST901999783.69
3203CA5A/GRPEL1 ratioGCST903135903.69
3204Sphingomyelin levelsGCST900929823.68
3205Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395ECGU0003953.68
3206ITGB5 levelsGCST904696453.68
3207Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389ECGU0003893.68
3208DIABLO/PRKAR1A ratioGCST903144693.68
3209CNTN3/FETUB ratioGCST903141643.68
3210Left-hemisphere dorsal attention network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026953.68
3211Androstenediol (3beta,17beta) disulfate (1) levelsGCST901998423.68
3212IDP dMRI ProbtrackX ICVF str lGCST900043983.68
3213Non-cancer illness code, self-reported - osteoarthritis | Medical conditionsUKBB000005213.67
3214DTI autoptx L3 ilf r tractGCST903852083.67
3215DTI autoptx L2 slf l tractGCST903851873.66
3216Radial peak diastolic strain rateGCST900190143.66
3217NOS3 levelsGCST904700643.66
3218IDP dMRI ProbtrackX ICVF ml rGCST900043933.66
3219Pain type(s) experienced in last month - Pain all over the body | PainUKBB000006323.66
3220CCN5/IGFBP6 ratioGCST903137233.65
3221NECTIN4 levelsGCST904700213.65
3222Emphysema (PheCode 496.1)GCST904760283.65
3223Left ventricular end diastole anterolateral wall thicknessGCST902785173.65
3224Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110ECGU0001103.65
3225Left molecular layer hippocampal volume (body)GCST902679533.65
3226CD58/LTBR ratioGCST903138513.64
3227LPO levelsGCST902417303.64
3228DTI TBSS MD Sagittal stratum RGCST903846023.64
3229ADGRD1 levelsGCST904682353.64
3230Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST904762203.64
3231Corneal hysteresis (right) | Intraocular pressureUKBB000001493.64
3232TNFAIP8L2 levelsGCST904708973.64
3233TNFRSF11B/TNFSF11 ratioGCST903159303.64
3234Microscopic polyangiitisFING000008173.64
3235SNX9/STIP1 ratioGCST903158643.64
3236GGT5 levelsGCST904693373.64
3237Major depressive disorder (ICD-10 coded)GCST0059033.63
3238ACE2/GGT1 ratioGCST903131533.63
3239Deep venous thrombosisGCST904681223.63
3240Corneal resistance factor (left) | Intraocular pressureUKBB000001503.62
3241IDP dMRI ProbtrackX L3 unc rGCST900043263.62
3242PDCD1LG2 levelsGCST904701803.62
3243ESAM/SORT1 ratioGCST903147163.62
3244CA4/FOLR2 ratioGCST903135853.62
3245Left ventricular wall thickness (maximal)GCST904352633.61
3246Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T186ECGU0001863.61
3247Total lipid levels in VLDLGCST900929993.61
3248aparc-DKTatlas lh volume caudalmiddlefrontalGCST900028643.61
3249Concentration of VLDL particlesGCST900930003.61
3250CD244/CD84 ratioGCST903137623.61
3251N6-methyllysine levels in chronic kidney diseaseGCST902575303.60
3252IGFBPL1 levelsGCST901793233.60
3253Concentration of small LDL particlesGCST904996693.60
3254Phospholipids in VLDLGCST905002663.60
3255Volume of right paralaminar nucleusGCST904749283.60
3256Oranges likingGCST900948073.60
3257Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354ECGA0003543.60
3258OPLAH levelsGCST904701273.60
3259IDP dMRI ProbtrackX ICVF atr lGCST900043773.60
3260Venous thromboembolismGCST903997443.59
3261Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T418ECGU0004183.58
3262Age when finished full-time education (weighted GWA)GCST902672813.58
3263T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST903206903.58
3264Globe artichoke likingGCST900947713.58
3265HMBS/PSMG3 ratioGCST903150643.58
3266Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T254ECGA0002543.58
3267APOA2 levelsGCST904683323.58
3268SELP levelsGCST904705693.58
3269CC2D1A levelsGCST904685573.58
3270SIAE/SNAP29 ratioGCST903158433.57
3271IDP dMRI TBSS L2 Uncinate fasciculus RGCST900041673.57
3272Polyunsaturated fatty acids to total fatty acids percentageGCST905021813.57
3273Neutrophil countGCST900259773.57
3274EIF4B levelsGCST904690943.57
3275Eustachian tube disorders (PheCode 381.2)GCST904759043.56
3276TNFRSF4/TNFRSF9 ratioGCST903159393.56
3277THTPA levelsGCST904708603.56
3278Bicuspidal aortic valve syndromeFING000002123.56
3279Pain type(s) experienced in last month - Knee pain | PainUKBB000006293.55
3280LCP1 levelsGCST904697483.55
3281NSFL1C levelsGCST904700893.55
3282SLITRK1 levelsGCST904706693.55
3283Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB000006253.55
3284ArthropathiesFING000001073.54
3285MELTF levelsGCST904698853.54
32861-stearoyl-2-oleoyl-GPS (18:0/18:1) levelsGCST901996523.54
3287Disorders of lacrimal systemFING000004413.54
3288DEFA1_DEFA1B/PTGDS ratioGCST903144553.54
3289AXIN1/HEXIM1 ratioGCST903134083.53
3290Pregnenediol sulfate (C21H34O5S) levelsGCST901998613.53
3291AMBP/RARRES2 ratioGCST903132563.53
3292Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T182ECGU0001823.53
3293GBP6 levelsGCST902413683.53
3294DLK1/FAP ratioGCST903144913.53
3295TCTN3 levelsGCST904708233.52
3296F9/FETUB ratioGCST903147463.52
3297Salad / raw vegetable intake | DietUKBB000007613.52
3298DSG2 levelsGCST904278253.52
3299Total lipid levels in lipoprotein particlesGCST905000863.52
3300IDP dMRI TBSS ICVF Superior longitudinal fasciculus RGCST900043673.52
3301Free Cholesterol to Total Lipids in Small HDL percentageGCST904994363.52
3302T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84)GCST903209033.51
3303Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T144ECGA0001443.51
3304REST UKBBICA NODEamps25 0009GCST903854923.51
3305Triacylglycerol_54:3_[M+NH4]1+ levelsGCST900605413.51
3306Left ventricular end systole anterospetal wall thicknessGCST902785133.51
3307MANF/NCK2 ratioGCST903153593.51
3308TGFB1 levelsGCST904708433.51
3309AHSP levelsGCST904682643.50
3310IDP dMRI TBSS OD Superior fronto-occipital fasciculus LGCST900044453.50
3311Abnormality of gait (PheCode 350.2)GCST904758413.50
3312Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021683.50
3313Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340ECGU0003403.50
3314Left ventricular end systole inferoseptal wall thicknessGCST902785083.50
3315THBS2 levelsGCST904708543.49
3316PDAP1 levelsGCST904701793.49
3317Pregnanediol-3-glucuronide levelsGCST901999173.49
3318IDP dMRI ProbtrackX OD str lGCST900044733.49
3319PTPRF levelsGCST904703813.49
3320FURIN levelsGCST904692773.49
3321Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)GCST901329513.49
3322Operative procedures - Fibreoptic endoscopic snare resection of lesion of colon | Summary OperationsUKBB000005793.48
3323PPIB levelsGCST904702913.48
3324NDUFB7 levelsGCST904700153.48
3325Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125ECGU0001253.48
3326Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132ECGU0001323.48
3327IL1B levelsGCST904695703.48
3328DTI autoptx L3 ptr l tractGCST903852123.48
3329GSTA3 levelsGCST904694123.48
3330IDP dMRI TBSS ICVF Cingulum hippocampus RGCST900043633.48
33311-(1-enyl-palmitoyl)-2-linoleoyl-GPC (p-16:0/18:2) levelsGCST902000603.48
3332NECTIN4/TGFBR2 ratioGCST903155353.47
3333Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903028203.47
3334SERPINA4 levelsGCST904705843.47
3335Free cholesterol levels in IDLGCST900928353.47
3336Fruit intake (standard GWA)GCST902672823.47
3337SERPINA3 levelsGCST904705833.46
3338Saturated fatty acids to total fatty acids percentageGCST905027003.46
3339SUSD4 levelsGCST904707883.46
3340DKK1/SERPINE1 ratioGCST903144803.46
3341VLDL cholesterol levelsGCST900929963.46
3342Free cholesterol in large LDL (UKB data field 23535)GCST902696323.45
3343Right ventricular end diastolic volume (MTAG)GCST901345923.45
3344Free cholesterol levels in medium VLDLGCST900929203.45
3345Cholesterol to total lipids ratio in medium HDLGCST900928933.45
3346Codeine or tramadol medicationFING000003113.45
3347PRTN3 levelsGCST904703483.45
3348Omega-6 fatty acid levelsGCST905025033.45
3349Autorefraction - 3mm asymmetry angle (left) | EyesightUKBB000000603.45
3350aparc-Desikan lh area fusiformGCST900030793.45
3351Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T319ECGU0003193.44
3352Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T67ECGU0000673.44
33531-(1-enyl-palmitoyl)-GPC (p-16:0) levelsGCST901998993.44
3354IDP dMRI TBSS MD Uncinate fasciculus RGCST900040713.44
3355Glycoprotein acetyls levelsGCST904973203.44
3356Nummular dermatitisFING000008933.43
3357Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987473.43
3358Omega-6 fatty acid levelsGCST905020953.43
3359Polyunsaturated fatty acid levelsGCST905021423.43
3360LRRC25 levelsGCST904698013.42
3361IDP T1 FAST ROIs L caudateGCST900025493.42
3362Trunk fat percentage | Impedance measuresUKBB000008643.42
3363SDC4 levelsGCST904705593.42
3364Concentration of medium VLDL particlesGCST900929233.41
3365red cell diameter width (RDW, mean, inv-norm transformed)GCST904763613.41
3366Total cholesterol minus HDL-C levelsGCST904991303.41
3367CREG1 levelsGCST904688573.41
3368ITGA5/VCAM1 ratioGCST903152063.41
3369CLEC4G levelsGCST904687743.41
3370HippSubfield rh volume Whole-hippocampal-bodyGCST900027093.41
3371Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T31ECGA0000313.41
3372High cholesterolGCST904681343.41
3373KYAT1 levelsGCST904697213.41
3374DTI TBSS L3 Superior corona radiata RGCST903845483.41
3375IDP dMRI ProbtrackX ICVF ilf lGCST900043893.40
3376IDP dMRI TBSS FA Anterior corona radiata RGCST900038993.40
3377Prescriptions - anti-malarialUKBB000006633.40
3378Prescriptions - quinine bisulfate | anti-malarialUKBB000006983.40
3379SCARF1 levelsGCST904705363.39
3380Other chondrocalcinosisFING000009773.39
3381Reticulocyte fraction of red cellsGCST900024063.39
3382ALDH1A1 levelsGCST904682803.39
3383DTI autoptx MD str l tractGCST903852433.39
3384Isoleucine levels (UKB data field 23465)GCST902695623.39
3385Biological Grandparent (maternal): Alzheimer's / Other DementiaGCST904754843.39
3386THBD levelsGCST904708533.39
3387OsteoarthritisGCST901342793.38
3388Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360ECGA0003603.38
3389Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286ECGA0002863.38
3390Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489ECGA0004893.38
3391Cholesterol to Total Lipids in Medium VLDL percentageGCST904989263.37
3392Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T187ECGU0001873.37
3393Right-hemisphere limbic network to thalamus white-matter structural connectivityGCST903028273.37
3394Total phospholipids in lipoprotein particles (UKB data field 23411)GCST902695083.37
3395IL18BP levelsGCST904695643.37
3396PLIN3 levelsGCST904702593.37
3397ESAM/PDGFB ratioGCST903147143.37
3398CD84/CDKN1A ratioGCST903139093.36
3399IL7R levelsGCST904696053.36
3400SNAP29/TJAP1 ratioGCST903158613.36
3401IDP dMRI ProbtrackX ICVF ifo lGCST900043873.36
3402Number of correct matches in round | Pairs matchingUKBB000005323.36
3403Retinal arteriolar widthGCST902703983.36
3404F2R/ITGB1BP2 ratioGCST903147313.36
3405Concentration of VLDL particlesGCST905002463.35
3406ABHD14B/CCS ratioGCST903131393.35
3407Follicle stimulating hormone levelsGCST904834763.35
3408PDGFB/VEGFC ratioGCST903156353.35
3409rfMRI amplitudes (ICA100 node 27)GCST900046153.35
3410TRIM21 levelsGCST904709643.35
3411BCHE levelsGCST904684293.35
3412Body mass index (BMI) | Body size measuresUKBB000001033.35
3413Father's age at death | Family historyUKBB000002413.35
3414CRKL levelsGCST904688673.34
3415Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112ECGU0001123.34
3416Cholesteryl ester levels in VLDLGCST900929973.33
3417T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST903206203.33
3418Lactate levels (UKB data field 23471)GCST902695683.33
3419Personal history of certain other diseases | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006423.33
3420Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347ECGA0003473.33
3421Myocardial fractal dimension (slice 4)GCST900002903.33
3422Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T337ECGA0003373.33
3423T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST903206093.33
3424IDP dMRI TBSS MD Anterior limb of internal capsule LGCST900040443.32
3425PSRC1/SMAD1 ratioGCST903157413.32
34261-stearoyl-gpc (18:0) levelsGCST901997323.32
3427Myocardial infarction, strictFING000008523.32
3428BA-exvivo rh area BA1GCST900032213.32
3429Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128ECGU0001283.32
3430CCDC80/CHRDL1 ratioGCST903136703.31
3431IDP dMRI TBSS ICVF Inferior cerebellar peduncle RGCST900043373.31
3432Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391ECGA0003913.31
3433JAM2/TGFBR2 ratioGCST903152383.30
3434Reticulocyte fraction of red cellsGCST0046193.30
3435SMPDL3A levelsGCST904706863.30
3436ST3GAL1 levelsGCST904707523.30
3437Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T359ECGU0003593.30
3438AHSP/BLVRB ratioGCST903132143.30
3439Total lipid levels in medium VLDLGCST900929223.30
3440VASH1 levelsGCST904710263.29
3441ILKAP levelsGCST904696083.29
3442Mental and behavioural disorders due to use of other stimulants, including caffeineFING000008113.29
3443IFNGR1 levelsGCST904695133.29
3444CXCL3 levelsGCST904689313.28
3445Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T252ECGU0002523.28
3446HippSubfield lh volume Whole-hippocampal-bodyGCST900026873.28
3447Disorders of breastFING000004373.27
3448Cholesteryl esters to total lipids ratio in medium HDLGCST900928953.27
3449Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T317ECGU0003173.27
3450Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T94ECGU0000943.27
3451Cholesteryl esters to total lipids ratio in large HDLGCST900928473.26
3452ITGB1BP2/PTPN6 ratioGCST903152183.26
3453Phospholipid levels in medium VLDLGCST900929243.26
3454Omega-6 fatty acids to total fatty acids percentageGCST904992033.26
3455Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T393ECGU0003933.26
3456Inpatient record format - UK HES In Patient (2015 format) | Summary AdministrationUKBB000003643.26
3457T1 FreeSurfer BA lh V2 exvivo thicknessGCST903855293.26
3458ACTA2 levelsGCST904682083.26
3459Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334ECGU0003343.25
3460Concentration of medium LDL particlesGCST904988233.25
3461Haemoglobin concentration | Blood countUKBB000002933.25
3462BAG6 levelsGCST904684183.25
3463SIGLEC9 levelsGCST904706373.25
3464CASP8/DDX58 ratioGCST903136513.25
3465S100A13 levelsGCST904705143.24
3466BIRC2/CD40LG ratioGCST903135173.24
3467T1 FreeSurfer DKT rh fusiform thicknessGCST903843223.24
3468ADH4/SCLY ratioGCST903131953.24
3469High light scatter reticulocyte percentage (UKB data field 30290)GCST904680773.24
3470Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T392ECGU0003923.23
3471NECTIN2/VSIR ratioGCST903155333.23
3472Alzheimer's disease (MTAG)GCST904490553.23
3473MILR1 levelsGCST904699073.23
3474ALCAM/NOTCH1 ratioGCST903132413.23
3475Total bilirubin levelsGCST902786433.23
3476High light scatter reticulocyte count | Blood countUKBB000003263.23
3477FETUB levelsGCST904692153.23
3478MVK levelsGCST904699673.23
3479NEFL levelsGCST904700243.23
3480Other chronic ischemic heart disease, unspecified (PheCode 411.8)GCST904759383.23
3481aparc-a2009s lh area S-oc-middle+LunatusGCST900033533.22
3482Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T344ECGA0003443.22
3483Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T362ECGU0003623.21
3484CPB1/CTRB1 ratioGCST903142083.21
3485CCN2/MGLL ratioGCST903137143.21
3486Concentration of medium VLDL particlesGCST904990163.21
3487Left-hemisphere default mode network to putamen white-matter structural connectivityGCST903027693.21
3488PLPBP levelsGCST904702603.20
3489PIK3IP1/TNFRSF1A ratioGCST903156533.20
3490HBB levelsGCST900259693.20
3491CBLN4 levelsGCST904685543.20
3492ALDH1A1/PKLR ratioGCST903132453.20
3493PRSS2 levelsGCST904703433.19
3494BACH1/SNX9 ratioGCST903134473.19
3495Total cholesterol levelsGCST902786443.19
3496GRAP2/SNX9 ratioGCST903149883.19
3497SIL1 levelsGCST904706383.18
3498Reaction time (standard GWA)GCST902672963.18
3499Frequency of tenseness / restlessness in last 2 weeks | Mental healthUKBB000002673.18
3500DTI TBSS L3 FornixGCST903845293.18
3501GoutGCST903997003.18
3502FGF5 levelsGCST904692263.17
3503LEPR/NRCAM ratioGCST903153123.17
3504Acute pulmonary heart disease (PheCode 415.1)GCST904759443.17
3505Alanine aminotransferase levelsGCST902786173.17
3506LGALS7 or LGALS7B levelsGCST904697633.17
3507DTI TBSS MD Cingulum cingulate gyrus RGCST903846063.17
3508Seated height | Body size measuresUKBB000007633.17
3509IGSF9 levelsGCST904695413.16
3510Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417ECGU0004173.16
3511BAG6/WASF1 ratioGCST903134523.16
3512Mean corpuscular hemoglobin concentrationGCST0046053.16
3513Phospholipids to total lipids ratio in medium HDLGCST900929013.16
3514Total Lipids in LDLGCST904984053.16
3515Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T244ECGU0002443.15
3516Biological Sibling: High cholesterolGCST904763713.15
3517Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T154ECGA0001543.15
3518X-18601 levelsGCST902435013.15
3519EGFLAM levelsGCST904216513.15
3520CASP8/PRDX6 ratioGCST903136553.15
3521Gestational age at birth (maternal effect)GCST902684193.15
3522CD69 levelsGCST904686433.15
3523Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T250ECGU0002503.14
3524Mood swings | Mental healthUKBB000004823.14
3525HDL x low social support interaction (2df test)GCST905706693.14
3526COL28A1 levelsGCST904688153.14
3527Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T146ECGA0001463.14
3528Lactate levelsGCST900928823.14
3529ATXN10 levelsGCST904684013.14
3530AmygNuclei lh volume Accessory-Basal-nucleusGCST900026503.14
3531Cholesterol in very small VLDL (UKB data field 23519)GCST902696163.13
3532aparc-pial lh area lateralorbitofrontalGCST900031523.13
3533Disorders of lipid metabolism (PheCode 272)GCST904757153.13
3534CNTN2 levelsGCST904688043.13
3535Hair colour (natural, before greying) - Light brown | Sun exposureUKBB000002983.13
3536RP2 levelsGCST904704933.13
3537Ankylosing spondylitisFING000000893.12
3538Non-cancer illness code, self-reported - gout | Medical conditionsUKBB000005123.11
3539F7/F9 ratioGCST903147433.11
3540SDC1 levelsGCST904705583.11
3541DTI TBSS MD Superior longitudinal fasciculus LGCST903846133.11
3542GLO1 levelsGCST904693583.11
3543IDP dMRI TBSS ICVF Sagittal stratum LGCST900043583.11
3544Hemoglobin concentrationGCST0046153.11
3545Recent feelings of foreboding | AnxietyUKBB000007383.11
3546Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T488ECGA0004883.10
3547GP1BA/SELP ratioGCST903149583.10
3548Hemorrhoids | circulatory systemUKBB000003253.10
3549CCL15 levelsGCST904685673.10
3550Operation code - carpal tunnel surgery | OperationsUKBB000005533.10
3551Principal component-derived dietary pattern 42GCST901330473.10
3552CKB levelsGCST904687593.10
35531-palmitoyl-2-oleoyl-GPE (16:0/18:1) metabolite levelGCST906164033.09
3554SarcoidosisGCST900186983.09
3555YAP1 levelsGCST904710863.08
3556MTDH levelsGCST904699543.08
3557Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009493.08
3558Cereal type - Oat cereal (e.g. Ready Brek, porridge) | DietUKBB000001243.08
3559Diacylglycerol_34:1_[M+H-H2O]1+ levelsGCST900601793.08
3560FAS levelsGCST904691923.08
3561RWDD1 levelsGCST904705103.08
3562DAB2 levelsGCST904689423.08
3563STK11 levelsGCST904707653.08
3564CDH6/NTRK2 ratioGCST903139623.08
3565HDL cholesterol levels (UKB data field 30760)GCST904680753.07
3566aparc-a2009s lh thickness S-postcentralGCST900036693.07
3567High light scatter reticulocyte percentage | Blood countUKBB000003273.07
3568Body mass index (BMI) | Impedance measuresUKBB000001043.07
3569Coronary heart diseaseGCST0009983.07
3570DFFA levelsGCST904689873.07
3571Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T85ECGU0000853.07
3572ACVRL1/TNFRSF10B ratioGCST903131583.06
3573CCL25/PRSS27 ratioGCST903136943.06
3574HMOX1 levelsGCST904694653.06
3575Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T138ECGA0001383.06
3576Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353ECGA0003533.06
3577Phospholipids to Total Lipids in IDL percentageGCST904976423.06
3578CD46 levelsGCST904686343.06
3579ALKBH3 levelsGCST906190953.05
3580Omega-6 fatty acids to total fatty acids percentageGCST904992103.05
3581IDP dMRI ProbtrackX ICVF slf lGCST900043963.05
3582COMP/THBS4 ratioGCST903141933.05
3583Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T257ECGA0002573.05
3584Phospholipids in LDL (UKB data field 23413)GCST902695103.05
3585Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T162ECGA0001623.04
3586Alzheimer's disease (MTAG)GCST904490623.04
3587Hippocampal subfield left CA4 volume (head)GCST902679433.04
3588Job involves heavy manual or physical work | EmploymentUKBB000003833.04
3589Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T47ECGA0000473.04
3590SLPI levelsGCST904260303.04
3591ALB levelsUKBB000000193.04
3592Right ventricular end diastolic volumeGCST901345883.03
3593Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904996023.03
3594Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T188ECGU0001883.03
3595Phospholipids in IDL (UKB data field 23525)GCST902696223.03
3596Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T143ECGA0001433.03
3597Alzheimer's disease or family history of Alzheimer's diseaseGCST900128773.03
3598Heart failure and coronary heart diseaseFING000006043.03
3599F-fruit liking (derived food-liking factor)GCST900947673.02
3600VLDL cholesterol levelsGCST905001963.02
3601Total fatty acid levelsGCST905022203.01
3602Noninfectious gastroenteritis | digestiveUKBB000005263.01
3603IDP dMRI TBSS MD Uncinate fasciculus LGCST900040723.01
3604Phosphatidylcholine-2O_32:0_[M+H]1+ levelsGCST900602443.01
3605MED18/SMAD1 ratioGCST903154133.01
3606aparc-Desikan lh area lateraloccipitalGCST900030833.01
3607Other serious medical condition/disability diagnosed by doctor | Medical conditionsUKBB000006193.01
3608Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T326ECGA0003263.00
3609wg rh intensity-contrast insulaGCST900038613.00
3610Whole body fat free mass (UKB data field 23101)GCST904281203.00
3611ACVRL1/SCARB2 ratioGCST903131573.00
3612PROK1 levelsGCST904703363.00
3613Ischemic Heart Disease | circulatory systemUKBB000003812.99
3614EIF4EBP1 levelsGCST904690952.99
3615Total fatty acid levelsGCST905000612.99
3616Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T129ECGU0001292.99
3617Pelvic widthGCST904489112.98
3618Testosterone levelsGCST904834862.98
3619FLI1 levelsGCST904692472.98
3620PDGFA/SERPINE1 ratioGCST903156182.98
3621high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed)GCST904753502.98
3622LDLRAP1 levelsGCST904697492.97
3623RET levelsGCST904704582.97
3624SPARCL1 levelsGCST902428702.97
3625acne vulgarisGCST902458182.97
3626Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T487ECGA0004872.97
3627Platelet countGCST900023582.96
3628Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T5ECGA0000052.96
3629F8 levelsGCST902407252.96
3630PTPRZ1 levelsGCST904703882.96
3631DTI TBSS MD Anterior limb of internal capsule LGCST903845892.95
3632Intracerebral hemorrhageGCST900186502.95
3633DTI TBSS L3 External capsule LGCST903845572.95
36341-ribosyl-imidazoleacetate levelsGCST901998152.95
3635Sphingomyelin_39:1_[M+H]1+ levelsGCST900603282.95
3636Triacylglycerol_50:4_[M+NH4]1+ levelsGCST900604662.95
3637Left-hemisphere control network to thalamus white-matter structural connectivityGCST903027522.95
3638DTI autoptx L1 ilf l tractGCST903851532.94
3639ARHGEF12/DECR1 ratioGCST903133492.94
3640Right-hemisphere control network to thalamus white-matter structural connectivityGCST903028362.94
3641Alzheimer's disease (MTAG)GCST904490582.94
3642IDP dMRI ProbtrackX FA unc rGCST900039512.94
3643Total lipids in lipoprotein particles (UKB data field 23423)GCST902695202.94
3644Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206ECGU0002062.94
3645Total lipids in small LDLGCST904996522.94
3646Crisps likingGCST900947472.94
3647CD300C/CLEC14A ratioGCST903137862.93
3648EPO levelsGCST904691362.93
3649Right-hemisphere control network to hippocampus white-matter structural connectivityGCST903028402.93
3650aseg lh volume CerebralWhiteMatterGCST900026152.93
3651aseg rh volume Lateral-VentricleGCST900026332.93
3652DTI autoptx L3 ifo r tractGCST903852062.93
3653TGFBR2 levelsGCST904708472.93
3654Stool frequencyGCST900022502.93
3655Metabolic syndromeGCST904444872.93
3656BPIFB1/GLRX ratioGCST903135302.92
3657DGKA levelsGCST904689892.92
3658Small cell lung carcinomaGCST0047462.92
3659Hyperlipidemia (PheCode 272.1)GCST904757182.92
3660Free cholesterol levels in VLDLGCST900929982.92
3661HSPG2/VASN ratioGCST903150942.92
3662Right ventricular end systolic volumeGCST901345892.92
3663FLT4 levelsGCST904692522.91
3664F-seafood liking (derived food-liking factor)GCST900948362.91
3665RadiculopathyFING000012382.91
3666AKT1S1 levelsGCST904682762.91
3667HGF/PDGFB ratioGCST903150582.91
3668Uterine leiomyomataGCST902398562.91
3669Total Lipids in Medium LDLGCST904988062.91
3670Urinary ethanolamine to urinary creatinine ratioGCST904517172.91
3671Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419ECGU0004192.91
3672Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T120ECGA0001202.91
3673Number of diet questionnaires completed | Diet questionnaire performanceUKBB000005362.90
3674Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T153ECGA0001532.90
3675Principal component-derived dietary pattern 1GCST901330062.90
3676Cancer of liver and intrahepatic bile duct (PheCode 155)GCST904755682.90
3677Peripheral vascular diseaseGCST904759962.90
3678Anterior thigh muscle fat infiltration percentageGCST902673512.90
3679TPI1 levelsGCST900886592.90
3680ThalamNuclei rh volume VAmcGCST900027472.90
3681Retinal thickness (functional principal component 5)GCST904557252.90
3682MGLL levelsGCST904699012.89
3683GFRA1/TNFRSF1A ratioGCST903149242.89
3684Nonspecific chest pain | circulatory systemUKBB000005272.89
3685Pneumoconiosis due to other inorganic dustsFING000011732.89
3686AKR1B1 levelsGCST904682732.89
3687aparc-a2009s lh volume S-subparietalGCST900029952.89
3688SMOC1 levelsGCST904706822.89
3689NELL2 levelsGCST904700272.89
3690OsteoarthritisGCST904681442.89
3691MANSC4 levelsGCST904698482.89
3692KIRREL2/PLA2G1B ratioGCST903152512.89
3693HEXIM1/IKBKG ratioGCST903150452.89
3694PolyarthrosisFING000011812.88
3695Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T155ECGA0001552.88
3696Inflammatory markers and poor diet (confirmatory factor analysis Factor 30)GCST903093642.88
3697Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697182.88
3698Cholesteryl esters in LDL (UKB data field 23417)GCST902695142.87
3699FOXJ3 levelsGCST904692642.87
3700Free Cholesterol in VLDLGCST905002212.87
3701Pulmonary embolism and infarction, acute (PheCode 415.11)GCST904759462.87
3702OMD/SPP1 ratioGCST903155862.87
3703CHAD levelsGCST904687372.87
3704IDP T1 FAST ROIs brain stemGCST900025612.87
3705CST3/RETN ratioGCST903142972.87
3706PDGFB/SDC4 ratioGCST903156262.87
3707CELA3A/CTRC ratioGCST903140122.87
3708Right-hemisphere control network to right-hemisphere control network white-matter structural connectivityGCST903028342.87
3709Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T394ECGU0003942.86
3710Free cholesterol in IDL (UKB data field 23528)GCST902696252.86
3711Reticulocyte count | Blood countUKBB000007522.86
3712Urine taurocholenate sulfate* levels in chronic kidney diseaseGCST902660412.86
3713Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T149ECGA0001492.86
37141-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levelsGCST902000652.86
3715Type of accommodation lived in - A flat, maisonette or apartment | HouseholdUKBB000008682.85
3716Occupational creativityGCST903087742.85
3717Total lipids in medium VLDLGCST904990042.85
3718Colorectal cancer, excluding all cancers (controls excluding all cancers)FING000003172.85
3719Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46ECGA0000462.85
3720UBA9475 sp002161235 abundance in stoolGCST900326352.85
3721GALNT7 levelsGCST904692992.85
3722HEPH levelsGCST904694462.85
3723Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T385ECGU0003852.85
3724DepressionFING000003982.84
3725ACRBP levelsGCST904682052.84
3726Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T76ECGA0000762.84
3727High light scatter reticulocyte count (UKB data field 30300)GCST904680762.83
3728DPEP2 levelsGCST904690312.83
3729Cardiorespiratory fitness slopeGCST900933202.83
3730MED18/SH2B3 ratioGCST903154122.83
3731DTI TBSS FA Anterior corona radiata RGCST903844022.83
3732NECTIN2/SDC1 ratioGCST903155292.83
3733Cholesteryl ester levels in LDLGCST900928842.82
3734Ischemic heart disease (PheCode 411)GCST904759292.82
3735Free Cholesterol to Total Lipids in Large LDL percentageGCST904980002.82
3736Propionylcarnitine levelsGCST902435932.82
3737Reticulocyte count (UKB data field 30250)GCST904681002.82
3738IDP dMRI TBSS L3 Body of corpus callosumGCST900041742.81
3739TMPRSS5 levelsGCST904708932.81
3740Degree of unsaturationGCST905022332.81
3741CLEC1B/DAB2 ratioGCST903140862.81
3742Congenital iodine-deficiency syndrome/hypothyroidismFING000003282.81
3743Childhood maltreatmentGCST905518322.81
3744Neutrophill count (UKB data field 30140)GCST904680922.81
3745Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T380ECGU0003802.81
3746Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020772.81
3747Multi-trait sex scoreGCST902701162.80
3748UrticariaGCST900187162.80
3749Right ventricular stroke volumeGCST901345902.80
3750HSPB1/QDPR ratioGCST903150892.80
3751AGXT/GRPEL1 ratioGCST903132052.80
3752Calcium | Blood biochemistryUKBB000001142.80
3753CLSTN2 levelsGCST904687892.79
3754Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T152ECGA0001522.79
3755CardiomyopathyGCST903997052.79
3756NRGN levelsGCST904700832.78
3757DTI TBSS FA Retrolenticular part of internal capsule RGCST903844002.78
3758Cholesteryl Esters in LDLGCST904983632.78
3759CANT1/HSPB1 ratioGCST903136172.78
3760Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T392ECGA0003922.78
3761total cholesterol (maximum, inv-norm transformed)GCST904764202.78
3762S100A4 levelsGCST904705182.78
3763B4GALT1/SMOC2 ratioGCST903134332.78
3764DTI TBSS MD Posterior thalamic radiation LGCST903846012.78
3765Subarachnoid hemorrhageGCST900187032.77
3766Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T309ECGU0003092.77
3767Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111ECGU0001112.77
3768Cholesteryl esters in very small VLDL (UKB data field 23520)GCST902696172.77
3769Concentration of LDL particlesGCST904984132.77
3770Pelvic heightGCST904489122.77
3771Calcium levels (UKB data field 30680)GCST904680652.77
3772Carboplatin drug response (IC50)GCST900117832.77
3773Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T325ECGA0003252.76
3774Thyroid stimulating hormone levelsGCST903193212.76
3775MANSC1/PODXL2 ratioGCST903153712.76
3776T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52)GCST903208712.76
3777ANXA3 levelsGCST904683182.76
3778Hair colour (natural, before greying): Light brown (UKB data field 1747_3)GCST900418382.76
3779Right ventricular peak atrial filling rateGCST902681192.75
3780aparc-a2009s rh thickness Pole-occipitalGCST900037182.75
3781CCN5 levelsGCST904685912.75
3782Kidney transplant statusFING000007102.75
3783aparc-Desikan lh volume caudalmiddlefrontalGCST900027712.75
3784Phospholipids to Total Lipids in Medium VLDL percentageGCST904990432.75
3785Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308ECGU0003082.75
3786CPB1/REG1A ratioGCST903142122.75
3787Total lipid levels in LDLGCST900928862.74
3788DTD1 levelsGCST904690452.74
3789Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228ECGA0002282.74
3790Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987832.74
3791FOLH1 levelsGCST904271922.74
3792Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276382.74
3793Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T30ECGA0000302.74
3794Free cholesterol to total lipids ratio in IDLGCST900928362.74
3795Disorders of other endocrine glandsFING000004502.73
3796Water consumption (glasses per day) (UKB data field 1528)GCST901329852.73
3797T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66)GCST903206292.73
3798Total Lipids in Medium LDLGCST904988002.73
3799HPGDS levelsGCST904694722.73
3800DTI autoptx L2 slf r tractGCST903851882.73
3801Coronary artery disease (confirmatory factor analysis Factor 16)GCST903093502.72
3802DBI/TMSB10 ratioGCST903144142.72
3803Thyroxine levelsGCST902002932.72
3804Total lipids in large LDL (UKB data field 23531)GCST902696282.72
3805F-strong vegetable liking (derived food-liking factor)GCST900948522.72
3806DPP4/ITGB1 ratioGCST903145402.72
3807IDP T1 FIRST right pallidum volumeGCST900024432.72
3808Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T73ECGU0000732.71
3809Mean corpuscular hemoglobinGCST900187442.71
3810Omega-6 fatty acid levelsGCST905025022.71
3811Cholesteryl Esters in VLDLGCST905002112.71
3812Duration of walks | Physical activityUKBB000002002.71
3813Right ventricular stroke volume (MTAG)GCST901345942.71
3814Vitamin D levelsGCST0053672.71
3815EPHA2 levelsGCST904691302.71
3816Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369ECGU0003692.71
3817Facial pigmentation measurement (UV light)GCST900022832.71
3818Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731)GCST904762462.70
3819Use of disulfiram, acamprosate or naltrexoneFING000014102.70
3820IDP dMRI TBSS MO Superior corona radiata RGCST900039762.70
3821FUT3_FUT5/LILRA2 ratioGCST903148892.70
3822Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420ECGU0004202.70
3823Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T327ECGA0003272.70
3824Subpubic angleGCST904489082.70
3825Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T151ECGA0001512.70
3826Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T131ECGA0001312.70
3827X-24947 levelsGCST902006512.69
3828NECTIN2 levelsGCST904700202.69
3829aparc-Desikan lh volume lateraloccipitalGCST900027782.69
3830CCL11 levelsGCST902747642.69
3831T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 87)GCST903209062.69
3832HemoglobinGCST900023842.69
3833CLEC1B/TXNDC5 ratioGCST903141052.69
3834CD274/EFNA4 ratioGCST903137682.69
3835Treatment speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB000008352.69
3836VNN1 levelsGCST904710432.69
3837Neutrophill count | Blood countUKBB000004972.69
3838VTA1 levelsGCST904710582.69
3839Phospholipids to Total Lipids in Small LDL percentageGCST904996902.68
3840Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904995952.68
3841NFU1 levelsGCST904700402.68
3842Depressive episode | Mood [affective] disordersUKBB000001662.68
3843DTI autoptx L2 atr r tractGCST903851692.68
3844SERPINB1 levelsGCST904705892.68
3845Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T350ECGA0003502.67
3846C20:4 Lysophosphatidylcholine levels in chronic kidney diseaseGCST902575702.67
3847Feeling miserableGCST0069432.67
3848LACTB2 levelsGCST904697262.67
3849Hip circumference | Body size measuresUKBB000003282.67
3850mean corpuscular hemoglobin concentration (MCHC, mean, inv-norm transformed)GCST904754582.67
3851Polyunsaturated fatty acid levelsGCST900929392.67
3852CTF1 levelsGCST904689012.67
3853Duration of heavy DIY | Physical activityUKBB000001952.67
3854DTI TBSS L3 Retrolenticular part of internal capsule RGCST903845442.67
3855Linoleic acid levels (UKB data field 23449)GCST902695462.66
3856Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T3ECGA0000032.66
3857Polyunsaturated fatty acids levels (UKB data field 23446)GCST902695432.66
3858IDP dMRI ProbtrackX FA str lGCST900039482.66
3859NCAM2 levelsGCST904700042.65
3860Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358ECGU0003582.65
3861IL18R1 levelsGCST904695652.65
3862DTI TBSS L3 Anterior corona radiata RGCST903845462.65
3863VAMP8 levelsGCST904710252.65
3864IDP dMRI ProbtrackX ISOVF cgc lGCST900045292.64
3865Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T300ECGU0003002.64
3866Free Cholesterol to Total Lipids in Medium VLDL percentageGCST904989882.64
3867High cholesterolGCST904752052.64
3868EFNA1/PIK3IP1 ratioGCST903145982.64
3869LDL (standard GWA)GCST902672722.64
3870GAS6/NOTCH1 ratioGCST903149182.64
3871AXIN1/MAVS ratioGCST903134142.64
3872Phosphatidylcholine-O_34:1_[M+H]1+/Phosphatidylcholine-P_34:0_[M+H]1+/Phosphatidylethanolamine-O_37:1_[M+H]1+ levelsGCST900602842.64
3873MAD1L1/POLR2F ratioGCST903153542.63
3874ENO3 levelsGCST904691112.63
3875IDP dMRI ProbtrackX L1 fmiGCST900042572.63
3876NT5C levelsGCST904700922.63
3877Spontaneous coronary artery dissectionGCST902458782.63
3878FKBP4/SIRT2 ratioGCST903148412.63
3879ITGA5 levelsGCST904696352.63
3880Free Cholesterol in LDLGCST904983862.63
3881CSF1 levelsGCST904688812.63
3882TANK levelsGCST904708032.62
3883Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344ECGU0003442.62
3884Alcohol consumption (drinks per month) (UKB data field 1578, 4424)GCST901329922.62
3885Cerebrospinal fluid sulfate* levelsGCST903180562.62
3886CD163/FOLR2 ratioGCST903137342.62
3887IDO1 levelsGCST902414902.61
3888Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T81ECGA0000812.61
3889Cholesterol to Total Lipids in Medium LDL percentageGCST904987142.61
3890Irritable bowel syndromeFING000007022.61
3891SEZ6 levelsGCST904706082.61
3892DTI TBSS MD External capsule LGCST903846052.61
3893Hallux valgus (Bunion) | musculoskeletalUKBB000002992.60
3894X-13671 levelsGCST902438292.60
3895GLA levelsGCST904693542.60
3896Monoclonal gammopathy of undetermined significanceGCST906247452.60
3897ENPP2 levelsGCST904691152.60
3898TMSB10 levelsGCST904708942.60
3899Administrative and legal statuses - NHS patient: not formally detained | Summary AdministrationUKBB000000122.60
3900Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T156ECGA0001562.59
3901HLA-DQA2 levelsGCST904270492.59
3902APRT levelsGCST904683452.59
3903Total lipids in LDL (UKB data field 23425)GCST902695222.59
3904CLEC1B/LBR ratioGCST903140952.59
3905Right-hemisphere limbic network to hippocampus white-matter structural connectivityGCST903028312.59
3906Pyruvate levelsGCST900929422.59
3907Neutrophil countGCST0046292.59
3908SERPINB6 levelsGCST904705912.58
3909CXCL13 levelsGCST904689262.58
3910Fibromuscular dysplasiaGCST900266122.58
3911SPTLC1 levelsGCST904271302.58
3912triglyceride (mean, inv-norm transformed)GCST904764332.58
3913ADAMTS4 levelsGCST904682262.58
3914Cholesteryl Esters in Medium LDLGCST904987392.58
3915BLVRB/CA1 ratioGCST903135212.58
3916NUCB2/TRIAP1 ratioGCST903155772.57
3917KLK8 levelsGCST904697072.57
3918Arterial stiffness indexGCST0084032.57
3919Right ventricular end diastolic volumeGCST902681162.57
3920Diacylglycerol_33:1_[M+H-H2O]1+ levelsGCST900601732.57
3921AGRN/BTN2A1 ratioGCST903131992.56
3922Red blood cell countGCST0046012.56
3923Left-hemisphere default mode network to thalamus white-matter structural connectivityGCST903027672.56
3924PSRC1 levelsGCST904703652.56
3925Arm fat percentage (left) | Impedance measuresUKBB000000452.56
3926Parental longevity (father's attained age)GCST0067012.56
3927T1 FreeSurfer aseg rhCerebralWhiteMatterVolGCST903841862.56
3928CCN1/DNAJB1 ratioGCST903137092.56
3929Monounsaturated fatty acid levelsGCST905020382.56
3930Deep vein thrombosis [DVT] (PheCode 452.2)GCST904760102.55
3931TOP1 levelsGCST904709332.55
3932ADAM9 levelsGCST904682212.55
3933DTI TBSS L2 Uncinate fasciculus LGCST903845212.55
3934Phosphatidylcholine-O_31:0_[M+H]1+/Phosphatidylethanolamine-O_34:0_[M+H]1+ levelsGCST900602432.55
3935aseg global volume-ratio BrainSegVol-to-eTIVGCST900026122.55
3936Hypercholesterolemia | endocrine/metabolicUKBB000003322.55
3937Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T55ECGA0000552.55
3938Glucose levelsGCST900928192.55
3939TRIM58 levelsGCST904709692.54
3940Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329ECGU0003292.54
3941ANXA3/HCLS1 ratioGCST903132822.54
3942PODXL2/SEZ6L ratioGCST903157022.54
3943Ischaemic heart disease, wide definitionFING000007032.54
3944Any dementia (more control exclusions)FING000000992.54
3945CD200/CNTNAP2 ratioGCST903137472.54
3946IDP dMRI TBSS MD Superior fronto-occipital fasciculus LGCST900040702.54
3947total cholesterol (maximum, inv-norm transformed)GCST904764182.54
3948CXCL11/ITGB1BP2 ratioGCST903143352.54
3949CDKN1A levelsGCST904686842.54
3950Cholesterol to Total Lipids in Medium LDL percentageGCST904987232.54
3951PDLIM7/SRC ratioGCST903156392.53
3952Cholesteryl esters in large LDL (UKB data field 23534)GCST902696312.53
3953IDP dMRI TBSS FA Anterior corona radiata LGCST900039002.53
3954IDP dMRI ProbtrackX ICVF mcpGCST900043912.53
3955HPCAL1/NUDC ratioGCST903150742.53
3956Cholesterol in IDL (UKB data field 23526)GCST902696232.53
3957Ascending aorta strainGCST902673882.53
3958LRIG1 levelsGCST904697942.53
3959Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB000005802.53
3960DTI TBSS L2 Posterior corona radiata RGCST903845022.53
3961IGF2R/RNASET2 ratioGCST903151322.53
3962RECK levelsGCST904704452.53
3963GP2/SELE ratioGCST903149622.52
3964CRELD2/F2R ratioGCST903142542.52
3965Adenomyosis (Endometriosis of uterus)FING000000422.52
3966Major dietary changes in the last 5 years - Yes, because of illness | DietUKBB000004222.52
3967BA-exvivo rh thickness BA2GCST900035282.52
3968APRT/NSFL1C ratioGCST903133372.52
3969wg lh intensity-contrast lateralorbitofrontalGCST900038032.52
3970IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus RGCST900043692.52
3971Generalized epilepsyFING000005672.52
3972Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T281ECGA0002812.52
3973X-17676 levelsGCST902005482.52
3974ZBTB16 levelsGCST904710952.52
3975TNFRSF21 levelsGCST904709122.51
3976FKBP4 levelsGCST904692432.51
3977aparc-pial lh area caudalmiddlefrontalGCST900031442.51
3978Linoleic acid levelsGCST900928802.51
3979DBH levelsGCST904689482.51
3980aparc-DKTatlas rh thickness transversetemporalGCST900036012.50
3981IDP dMRI ProbtrackX L3 str lGCST900043232.50
3982Spread type - Butter/spreadable butter | DietUKBB000007932.50
3983CCL5/TFPI ratioGCST903137082.50
3984NRSN1 levelsGCST902420622.50
3985Glutamine levelsGCST904972822.50
3986NCR3 levelsGCST900881792.49
3987CDA levelsGCST904686602.49
3988Stress incontinence, female | genitourinaryUKBB000007972.49
3989CEACAM8/PGLYRP1 ratioGCST903140032.49
3990Cholesterol in large LDL (UKB data field 23533)GCST902696302.49
3991Cholesterol to Total Lipids in Small LDL percentageGCST904995692.48
3992X-21364 levelsGCST902005662.48
3993Pulmonary heart disease (PheCode 415)GCST904759422.48
3994CDHR1 levelsGCST904686782.48
3995IDP dMRI ProbtrackX MD unc rGCST900042452.48
3996Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388ECGU0003882.48
3997DTI TBSS MD FornixGCST903845772.48
3998APOB levelsGCST904971372.48
3999Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987582.48
4000ALCAM/IL1RL2 ratioGCST903132382.47